Artelo Biosciences (ARTL) Debt Ratio (2017 - 2025)
Artelo Biosciences' (ARTL) Debt Ratio came in at 0.16 for Q4 2025, down 23.9% from the prior quarter.
Analysis
Artelo Biosciences (ARTL) Debt Ratio (2017 - 2025) Analysis & Trends
Since Q2 2017, Artelo Biosciences has reported Debt Ratio for 4 quarters.
- The Q4 2025 figure stands as the lowest quarterly Debt Ratio since Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.24 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Artelo Biosciences | 52,106.49 | -5.08 Mn | - | 0.16 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.21 |
| May 31, 2017 | 0.13 |
| Feb 28, 2017 | 2.20 |
API Access
Artelo Biosciences Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=ARTL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();